Biodesix Competitors and Similar CompaniesClear all
Biodesix's competitors and similar companies include Foundation Medicine, Guardant Health, Veracyte and OccamzRazor.
 Foundation Medicine Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies. |  Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy. |  Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. |  OccamzRazor OccamzRazor (also known as Razor) is a digital biotech company that provides the discovery and development of modality-agnostic treatments for brain aging disease. | ||
Founding Date | Founding Date 2005 | Founding Date 2010 | Founding Date 2012 | Founding Date 2008 | Founding Date 2015 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Boulder, US HQ De Soto, US | Locations Boston, US HQ Penzberg, DE Morrisville, US San Diego, US | Locations Redwood City, US HQ | Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US | Locations San Francisco, US HQ |
Employees | Employees 21711% decrease | Employees 1,8031% decrease | Employees 1,7681% decrease | Employees 8154% increase | Employees 11 |
Valuation ($) | Valuation ($) 239.5 m | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) 2.6 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $88.5m (FY, 2025) | Revenue (est.) $152.9m (FY, 2017) | Revenue (est.) $982m (FY, 2025) | Revenue (est.) $517.1m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $85.3m (FY, 2017) | Cost of goods $349m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $67.6m (FY, 2017) | Gross profit $633m (FY, 2025) | Gross profit $362.5m (FY, 2025) | Gross profit N/A |
Net income | Net income ($35.3m) (FY, 2025) | Net income ($161.5m) (FY, 2017) | Net income ($416.3m) (FY, 2025) | Net income $66.4m (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Completed Clinical Studies to Date | Completed Clinical Studies to Date 23 (Q2, 2020) | Completed Clinical Studies to Date N/A | Completed Clinical Studies to Date N/A | Completed Clinical Studies to Date 50 (FY, 2020) | Completed Clinical Studies to Date N/A |
Peer-Reviewed Publications | Peer-Reviewed Publications N/A | Peer-Reviewed Publications 500 (Jul, 2022) | Peer-Reviewed Publications 200 (FY, 2021) | Peer-Reviewed Publications N/A | Peer-Reviewed Publications N/A |
Funding | |||||
Total funding raised | Total funding raised $ 98.2m | Total funding raised $ 96.5m | Total funding raised $ 550m | Total funding raised $ 116.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Foundation Medicine
HQ
Boston, US
Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies.
View companyGuardant Health
HQ
Redwood City, US
Employees
1,768↓ 1% decrease
Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.
View companyVeracyte
HQ
South San Francisco, US
Employees
815↑ 4% increase
Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
View companyOccamzRazor
HQ
San Francisco, US
OccamzRazor (also known as Razor) is a digital biotech company that provides the discovery and development of modality-agnostic treatments for brain aging disease.
View company